Pregnancy Outcomes in HIV-Infected Women Receiving Long-Term Isoniazid Prophylaxis for Tuberculosis and Antiretroviral Therapy
Open Access
- 7 March 2013
- journal article
- research article
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 2013, 1-5
Abstract
Objective. While 6- to 12-month courses of isoniazid for tuberculosis prevention are considered safe in pregnant women, the effects of longer-term isoniazid prophylaxis or isoniazid in combination with antiretroviral therapy (ART) are not established in human-immunodeficiency-virus-(HIV-) infected women who experience pregnancy during the course of therapy.Design.Nested study of pregnancy outcomes among HIV-infected women participating in a placebo-controlled, TB-prevention trial using 36 months daily isoniazid. Pregnancy outcomes were collected by interview and record review.Results. Among 196 pregnant women, 103 (52.6%) were exposed to isoniazid during pregnancy; all were exposed to antiretroviral drugs. Prior to pregnancy they had received a median of 341 days (range 1–1095) of isoniazid. We observed no isoniazid-associated hepatitis or other severe isoniazid-associated adverse events in the 103 women. Pregnancy outcomes were 132 term live births, 42 premature births, 11 stillbirths, 8 low birth weight, 6 spontaneous abortions, 4 neonatal deaths, and 1 congenital abnormality. In a multivariable model, neither isoniazid nor ART exposure during pregnancy was significantly associated with adverse pregnancy outcome (adjusted odds ratios 0.6, 95% CI: 0.3–1.1 and 1.8, 95% CI 0.9–3.6, resp.).Conclusions. Long-term isoniazid prophylaxis was not associated with adverse pregnancy outcomes, such as preterm delivery, even in the context of ART exposure.Keywords
This publication has 23 references indexed in Scilit:
- Risk factors for very preterm delivery and delivery of very‐small‐for‐gestational‐age infants among HIV‐exposed and HIV‐unexposed infants in BotswanaInternational Journal of Gynecology & Obstetrics, 2011
- Epidemiology of congenital idiopathic talipes equinovarus in Iowa, 1997–2005American Journal of Medical Genetics Part A, 2010
- Isoniazid Tuberculosis Preventive Therapy in HIV-Infected Adults Accessing Antiretroviral Therapy: A Botswana Experience, 2004-2006JAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysisAIDS, 2007
- Idiopathic talipes equinovarus (ITEV) (clubfeet) in TexasAmerican Journal of Medical Genetics Part A, 2005
- Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in EuropeAIDS, 2004
- Antiretroviral Therapy during Pregnancy and the Risk of an Adverse OutcomeNew England Journal of Medicine, 2002
- Combination antiretroviral therapy and duration of pregnancyAIDS, 2000
- Obstetric and Newborn Outcomes in a Cohort of HIV-Infected Pregnant Women: A Report of the Women and Infants Transmission StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 1999
- Genetic and Epidemiological Studies of Clubfoot in HawaiiHuman Heredity, 1969